SYDNEY, AUSTRALIA: ImpediMed Limited (ASX: IPD), a medical device company that develops bioimpedance technology, has announced changes to its leadership and Board to improve its performance and profitability. The changes come after the Board conducted a review of the Company’s strategy and identified the need for better execution and cost control. The Company has appointed…